Browsing: Homepage Slider
Thermo Fisher Scientific Inc. (MA, USA) have announced new technologies that obtain high-resolution separations with increased sensitivity and reproducibility.
This editorial looks to highlight the major advantages of MS in the clinical laboratory, explain the major hurdles in place and provide an insight into the potential applications for clinical biomarker analysis.
Development of a UHPLC–MS/MS (SRM) method for the quantitation of endogenous glucagon and dosed GLP-1 from human plasma
In this research article, the authors discuss how the use of LC–MS/MS could offer a viable alternative to immunoassays for the quantitation of endogenous glucagon, dosed glucagon and/or dosed GLP-1.
Researchers have developed an innovative technique to detect tumor DNA in blood with a greater degree of sensitivity and precision.
Current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies
In this commentary, Kate Peng discusses the current thinking on quantification of protein therapeutic pharmacokinetics and protein biomarkers in clinical studies.
Bioanalysis and Bioanalysis Zone were proud to support the WRIB Poster Awards at the 11th WRIB – here we feature the three winning posters.
We interviewed Daniel Sikkema and John Lin (Frontage Laboratories) asking how they stay on top of innovative trends and bioanalytical advancements.
Available to view on demand
In this panel discussion our experts will analyze the results from our recent survey on the bioanalysis of biopharmaceuticals and biomarkers, providing a comprehensive overview and focusing on developing technologies and trends.